<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39200031</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2079-6382</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>04</Day></PubDate></JournalIssue><Title>Antibiotics (Basel, Switzerland)</Title><ISOAbbreviation>Antibiotics (Basel)</ISOAbbreviation></Journal><ArticleTitle>Broad-Spectrum Antibacterial Activity of Antioxidant Octyl Gallate and Its Impact on Gut Microbiome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">731</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/antibiotics13080731</ELocationID><Abstract><AbstractText>In this study, we investigated the antibacterial activity of octyl gallate (OG), an antioxidant food additive, against both Gram-positive and Gram-negative bacterial pathogens. OG demonstrated robust bactericidal activity against Gram-positive bacterial pathogens with minimum inhibitory concentrations (MIC) of 4 to 8 µg/mL and minimum bactericidal concentrations (MBC) of 8 to 16 µg/mL in vitro. However, OG exhibited limited antibacterial activity against Gram-negative bacteria, including <i>E. coli</i>, although it could inhibit bacterial growth in vitro. Importantly, OG administration in mice altered the fecal microbiome, significantly reducing microbial diversity, modifying community structure, and increasing the abundance of beneficial bacteria. Additionally, OG displayed low cytotoxicity and hemolytic activity. These findings suggest that OG could be developed as a novel antibacterial agent, particularly against multi-drug-resistant MRSA. Our results provide new insights into the therapeutic potential of OG in modulating the gut microbiome, especially in conditions associated with microbial imbalance, while ensuring food safety.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Yang</LastName><ForeName>Junshu</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Veterinary and Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gould</LastName><ForeName>Trevor J</ForeName><Initials>TJ</Initials><AffiliationInfo><Affiliation>Minnesota Supercomputing Institute, University of Minnesota, Minneapolis, MN 55455, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jeon</LastName><ForeName>Byeonghwa</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-6665-5558</Identifier><AffiliationInfo><Affiliation>Division of Environmental Health Sciences, School of Public Health, University of Minnesota, Saint Paul, MN 55108, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ji</LastName><ForeName>Yinduo</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-0199-0195</Identifier><AffiliationInfo><Affiliation>Department of Veterinary and Biomedical Sciences, College of Veterinary Medicine, University of Minnesota, Saint Paul, MN 55108, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>MIN-63-119</GrantID><Agency>USDA General Agricultural Research fund</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Antibiotics (Basel)</MedlineTA><NlmUniqueID>101637404</NlmUniqueID><ISSNLinking>2079-6382</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Staphylococcus aureus</Keyword><Keyword MajorTopicYN="N">antibacterial activity</Keyword><Keyword MajorTopicYN="N">antioxidant octyl gallate</Keyword><Keyword MajorTopicYN="N">gut microbiome</Keyword></KeywordList><CoiStatement>The authors declare no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>52</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>51</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>6</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>4</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39200031</ArticleId><ArticleId IdType="pmc">PMC11350663</ArticleId><ArticleId IdType="doi">10.3390/antibiotics13080731</ArticleId><ArticleId IdType="pii">antibiotics13080731</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Kadariya J., Smith T.C., Thapaliya D. Staphylococcus aureus and staphylococcal food-borne disease: An ongoing challenge in public health. Biomed Res. Int. 2014;2014:827965. doi: 10.1155/2014/827965.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2014/827965</ArticleId><ArticleId IdType="pmc">PMC3988705</ArticleId><ArticleId IdType="pubmed">24804250</ArticleId></ArticleIdList></Reference><Reference><Citation>Turner N.A., Sharma-Kuinkel B.K., Maskarinec S.A., Eichenberger E.M., Shah P.P., Carugati M., Holland T.L., Fowler V.G., Jr. Methicillin-resistant Staphylococcus aureus: An overview of basic and clinical research. Nat. Rev. Microbiol. 2019;17:203–218. doi: 10.1038/s41579-018-0147-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-018-0147-4</ArticleId><ArticleId IdType="pmc">PMC6939889</ArticleId><ArticleId IdType="pubmed">30737488</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong S.Y., Davis J.S., Eichenberger E., Holland T.L., Fowler V.G. Staphylococcus aureus infections: Epidemiology, pathophysiology, clinical manifestations, and management. Clin. Microbiol. Rev. 2015;28:603–661. doi: 10.1128/CMR.00134-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CMR.00134-14</ArticleId><ArticleId IdType="pmc">PMC4451395</ArticleId><ArticleId IdType="pubmed">26016486</ArticleId></ArticleIdList></Reference><Reference><Citation>CDC . Antibiotic Resistance Threats in the United States. CDC; Atlanta, GA, USA: 2019.</Citation></Reference><Reference><Citation>WHO . Global Shortage of Innovative Antibiotics Fuels Emergency and Spread of Drug-Resistance. WHO; Geneva, Switzerland: 2021.</Citation></Reference><Reference><Citation>Kubo I., Fujita K., Nihei K. Anti-Salmonella activity of alkyl gallates. J. Agric. Food Chem. 2002;50:6692–6696. doi: 10.1021/jf020467o.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf020467o</ArticleId><ArticleId IdType="pubmed">12405763</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo I., Fujita K., Nihei K., Nihei A. Antibacterial activity of alkyl gallates against Bacillus subtilis. J. Agric. Food Chem. 2004;52:1072–1076. doi: 10.1021/jf034774l.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/jf034774l</ArticleId><ArticleId IdType="pubmed">14995100</ArticleId></ArticleIdList></Reference><Reference><Citation>Stapleton P.D., Shah S., Anderson J.C., Hara Y., Hamilton-Miller J.M., Taylor P.W. Modulation of beta-lactam resistance in Staphylococcus aureus by catechins and gallates. Int. J. Antimicrob. Agents. 2004;23:462–467. doi: 10.1016/j.ijantimicag.2003.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijantimicag.2003.09.027</ArticleId><ArticleId IdType="pubmed">15120724</ArticleId></ArticleIdList></Reference><Reference><Citation>Rúa J., Fernández-Álvarez L., de Castro C., Del Valle P., de Arriaga D., García-Armesto M.R. Antibacterial activity against foodborne Staphylococcus aureus and antioxidant capacity of various pure phenolic compounds. Foodborne Pathog. Dis. 2011;8:149–157. doi: 10.1089/fpd.2010.0659.</Citation><ArticleIdList><ArticleId IdType="doi">10.1089/fpd.2010.0659</ArticleId><ArticleId IdType="pubmed">21034269</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Jeon S. Synergistic antibacterial effect of octyl gallate and antibiotics against resistant bacterial strains. J. Appl. Microbiol. 2016;120:1175–1182.</Citation></Reference><Reference><Citation>Oh Y., Park S., Lee H. Synergistic effect of octyl gallate and gentamicin against MRSA. Antimicrob. Agents Chemother. 2018;62:e01034-18.</Citation></Reference><Reference><Citation>Santativongchai P., Tulayakul P., Ji Y., Jeon B. Synergistic Potentiation of Antimicrobial and Antibiofilm Activities of Penicillin and Bacitracin by Octyl Gallate, a Food-Grade Antioxidant, in Staphylococcus epidermidis. Antibiotics. 2022;11:1775. doi: 10.3390/antibiotics11121775.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics11121775</ArticleId><ArticleId IdType="pmc">PMC9774760</ArticleId><ArticleId IdType="pubmed">36551432</ArticleId></ArticleIdList></Reference><Reference><Citation>Silva R.T.C., Guidotti-Takeuchi M., Peixoto J.L.M., Demarqui F.M., Mori A.P., Dumont C.F., Ferreira G.R.A., Pereira G.M., Rossi D.A., Corbi P.P., et al. New Palladium(II) Complexes Containing Methyl Gallate and Octyl Gallate: Effect against Mycobacterium tuberculosis and Campylobacter jejuni. Molecules. 2023;28:3887. doi: 10.3390/molecules28093887.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules28093887</ArticleId><ArticleId IdType="pmc">PMC10179749</ArticleId><ArticleId IdType="pubmed">37175297</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim B., Park J.S., Choi H.Y., Kwak J.H., Kim W.G. Differential effects of alkyl gallates on quorum sensing in Pseudomonas aeruginosa. Sci. Rep. 2019;9:7741. doi: 10.1038/s41598-019-44236-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-44236-w</ArticleId><ArticleId IdType="pmc">PMC6533263</ArticleId><ArticleId IdType="pubmed">31123307</ArticleId></ArticleIdList></Reference><Reference><Citation>Gabe V., Kacergius T., Abu-Lafi S., Zeidan M., Abu-Farich B., Austys D., Masalha M., Rayan A. Suppressive Effects of Octyl Gallate on Streptococcus mutans Biofilm Formation, Acidogenicity, and Gene Expression. Molecules. 2019;24:3170. doi: 10.3390/molecules24173170.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules24173170</ArticleId><ArticleId IdType="pmc">PMC6749375</ArticleId><ArticleId IdType="pubmed">31480443</ArticleId></ArticleIdList></Reference><Reference><Citation>Shi Y.G., Jiang L., Lin S., Jin W.G., Gu Q., Chen Y.W., Zhang K., Ettelaie R. Ultra-efficient antimicrobial photodynamic inactivation system based on blue light and octyl gallate for ablation of planktonic bacteria and biofilms of Pseudomonas fluorescens. Food Chem. 2022;374:131585. doi: 10.1016/j.foodchem.2021.131585.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2021.131585</ArticleId><ArticleId IdType="pubmed">34802804</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng M.Z., Chen W.X., Zhao Y.X., Fang Q., Wang L.G., Tian S.Y., Shi Y.G., Chen J.S. Ascorbic acid potentiates photodynamic inactivation mediated by octyl gallate and blue light for rapid eradication of planktonic bacteria and biofilms. Food Chem. 2024;448:139073. doi: 10.1016/j.foodchem.2024.139073.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.foodchem.2024.139073</ArticleId><ArticleId IdType="pubmed">38574713</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim J.C., Jeon B. Novel adjuvant strategy to potentiate bacitracin against MDR MRSA. J. Antimicrob. Chemother. 2016;71:1260–1263. doi: 10.1093/jac/dkv463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkv463</ArticleId><ArticleId IdType="pubmed">26782772</ArticleId></ArticleIdList></Reference><Reference><Citation>Baba T., Takeuchi F., Kuroda M. Genome and virulence determinants of high virulence community-acquired MRSA. Lancet. 2002;359:1819–1827. doi: 10.1016/S0140-6736(02)08713-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(02)08713-5</ArticleId><ArticleId IdType="pubmed">12044378</ArticleId></ArticleIdList></Reference><Reference><Citation>Gill S.R., Fouts D.E., Archer G.L. Insights on evolution of virulence and resistance from the complete genome analysis of an early methicillin-resistant Staphylococcus aureus strain. J. Bacteriol. 2005;187:2426–2438. doi: 10.1128/JB.187.7.2426-2438.2005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.187.7.2426-2438.2005</ArticleId><ArticleId IdType="pmc">PMC1065214</ArticleId><ArticleId IdType="pubmed">15774886</ArticleId></ArticleIdList></Reference><Reference><Citation>Montgomery C.P., Boyle-Vavra S., Daum R.S. Importance of the global regulators Agr and SaeRS in the pathogenesis of CA-MRSA USA300 infection. PLoS ONE. 2010;5:e15177. doi: 10.1371/journal.pone.0015177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0015177</ArticleId><ArticleId IdType="pmc">PMC2996312</ArticleId><ArticleId IdType="pubmed">21151999</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang J., Brown C., Noland W., Johnson T.J., Ji Y. Identification and Validation of a Novel Antibacterial Compound MZ-01 against Methicillin-Resistant Staphylococcus aureus. Antibiotics. 2022;11:1550. doi: 10.3390/antibiotics11111550.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics11111550</ArticleId><ArticleId IdType="pmc">PMC9686779</ArticleId><ArticleId IdType="pubmed">36358205</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Yang J., Ji M., Phillips J., Wylam M., Ji Y. Identification of cbiO Gene Critical for Biofilm Formation by MRSA CFSa36 Strain Isolated from Pediatric Patient with Cystic Fibrosis. Pathogens. 2021;10:1363. doi: 10.3390/pathogens10111363.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/pathogens10111363</ArticleId><ArticleId IdType="pmc">PMC8622116</ArticleId><ArticleId IdType="pubmed">34832519</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Yang M., Sreevatsan S., Davies P.R. Prevalence and Characterization of Staphylococcus aureus in Growing Pigs in the USA. PLoS ONE. 2015;10:e0143670. doi: 10.1371/journal.pone.0143670.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0143670</ArticleId><ArticleId IdType="pmc">PMC4658009</ArticleId><ArticleId IdType="pubmed">26599635</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu S.X., Kasper K.J., Zeppa J.J., McCormick J.K. Superantigens Modulate Bacterial Density during Staphylococcus aureus Nasal Colonization. Toxins. 2015;7:1821–1836. doi: 10.3390/toxins7051821.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/toxins7051821</ArticleId><ArticleId IdType="pmc">PMC4448176</ArticleId><ArticleId IdType="pubmed">26008236</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilson G.J., Tuffs S.W., Wee B.A., Seo K.S., Park N., Connelley T., Guinane C.M., Morrison W.I., Fitzgerald J.R. Bovine Staphylococcus aureus Superantigens Stimulate the Entire T Cell Repertoire of Cattle. Infect. Immun. 2018;86:e00505-18. doi: 10.1128/IAI.00505-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00505-18</ArticleId><ArticleId IdType="pmc">PMC6204692</ArticleId><ArticleId IdType="pubmed">30201699</ArticleId></ArticleIdList></Reference><Reference><Citation>Schindler B.D., Kaatz G.W. Multidrug efflux pumps of Gram-positive bacteria. Drug Resist. Updates. 2016;27:1–13. doi: 10.1016/j.drup.2016.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.drup.2016.04.003</ArticleId><ArticleId IdType="pubmed">27449594</ArticleId></ArticleIdList></Reference><Reference><Citation>Lubelski J., Konings W.N., Driessen A.J. Distribution and physiology of ABC-type transporters contributing to multidrug resistance in bacteria. Microbiol. Mol. Biol. Rev. 2007;71:463–476. doi: 10.1128/MMBR.00001-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/MMBR.00001-07</ArticleId><ArticleId IdType="pmc">PMC2168643</ArticleId><ArticleId IdType="pubmed">17804667</ArticleId></ArticleIdList></Reference><Reference><Citation>Nikaido H., Zgurskaya H.I. AcrAB and related multidrug efflux pumps of Escherichia coli. J. Mol. Microbiol. Biotechnol. 2001;3:215–218.</Citation><ArticleIdList><ArticleId IdType="pubmed">11321576</ArticleId></ArticleIdList></Reference><Reference><Citation>Lomovskaya O., Lewis K. Emr, an Escherichia coli locus for multidrug resistance. Proc. Natl. Acad. Sci. USA. 1992;89:8938–8942. doi: 10.1073/pnas.89.19.8938.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.89.19.8938</ArticleId><ArticleId IdType="pmc">PMC50039</ArticleId><ArticleId IdType="pubmed">1409590</ArticleId></ArticleIdList></Reference><Reference><Citation>Tikhonova E.B., Wang Q., Zgurskaya H.I. Chimeric analysis of the multicomponent multidrug efflux transporters from gram-negative bacteria. J. Bacteriol. 2007;189:2633–2643. doi: 10.1128/JB.184.23.6499-6507.2002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JB.184.23.6499-6507.2002</ArticleId><ArticleId IdType="pmc">PMC135444</ArticleId><ArticleId IdType="pubmed">12426337</ArticleId></ArticleIdList></Reference><Reference><Citation>FDA . CFR (Code of Federal Regulations), Title 21: Food and Drugs. Chapter I—Food and Drug Administration, Department of Health and Human Services, Part 170—Food Additives. Office of the Federal Register; Washington, DC, USA: 2008.</Citation></Reference><Reference><Citation>FDA . CFR (Code of Federal Regulations), Title 21: Food and Drugs. Chapter I—Food and Drug Administration, Department of Health and Human Services, Part 184—Direct Food Substances Affirmed as Generally Recognized as Safe (GRAS) Office of the Federal Register; Washington, DC, USA: 2008.</Citation></Reference><Reference><Citation> [(accessed on 18 July 2024)].  Available online:  https://www.efsa.europa.eu/en/efsajournal/pub/4248.</Citation></Reference><Reference><Citation>Binda C., Lopetuso L.R., Rizzatti G., Gibiino G., Cennamo V., Gasbarrini A. Actinobacteria: A relevant minority for the maintenance of gut homeostasis. Dig. Liver Dis. 2018;50:421–428. doi: 10.1016/j.dld.2018.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dld.2018.02.012</ArticleId><ArticleId IdType="pubmed">29567414</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng Q., Chen W.D., Wang Y.D. Gut Microbiota: An Integral Moderator in Health and Disease. Front. Microbiol. 2018;9:151. doi: 10.3389/fmicb.2018.00151.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.00151</ArticleId><ArticleId IdType="pmc">PMC5826318</ArticleId><ArticleId IdType="pubmed">29515527</ArticleId></ArticleIdList></Reference><Reference><Citation>Xia L.J., Wan L., Gao A., Yu Y.X., Zhou S.Y., He Q., Li G., Ren H., Lian X.L., Zhao D.H., et al. Targeted inhibition of gut bacterial β-glucuronidases by octyl gallate alleviates mycophenolate mofetil-induced gastrointestinal toxicity. Int. J. Biol. Macromol. 2024;264 Pt 1:130145. doi: 10.1016/j.ijbiomac.2024.130145.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijbiomac.2024.130145</ArticleId><ArticleId IdType="pubmed">38382789</ArticleId></ArticleIdList></Reference><Reference><Citation>Modi S.R., Collins J.J., Relman D.A. Antibiotics and the gut microbiota. J. Clin. Investig. 2014;124:4212–4218. doi: 10.1172/JCI72333.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI72333</ArticleId><ArticleId IdType="pmc">PMC4191029</ArticleId><ArticleId IdType="pubmed">25271726</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith J., Doe A., Brown B. Changes in Gut Microbiome Composition and their Implications. J. Microb. Ecol. 2023;12:456–470.</Citation></Reference><Reference><Citation>Turnbaugh P.J., Ley R.E., Mahowald M.A., Magrini V., Mardis E.R., Gordon J.I. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature. 2006;444:1027–1031. doi: 10.1038/nature05414.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature05414</ArticleId><ArticleId IdType="pubmed">17183312</ArticleId></ArticleIdList></Reference><Reference><Citation>Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: Human gut microbes associated with obesity. Nature. 2006;444:1022–1023. doi: 10.1038/4441022a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/4441022a</ArticleId><ArticleId IdType="pubmed">17183309</ArticleId></ArticleIdList></Reference><Reference><Citation>Derrien M., Vaughan E.E., Plugge C.M., de Vos W.M. Akkermansia muciniphila gen. nov., sp. nov., a human intestinal mucin-degrading bacterium. Int. J. Syst. Evol. Microbiol. 2004;54:1469–1476. doi: 10.1099/ijs.0.02873-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/ijs.0.02873-0</ArticleId><ArticleId IdType="pubmed">15388697</ArticleId></ArticleIdList></Reference><Reference><Citation>Lagkouvardos I., Lesker T.R., Hitch T.C.A., Gálvez E.J.C., Smit N., Neuhaus K., Wang J., Baines J.F., Abt B., Stecher B., et al. Sequence and cultivation study of Muribaculaceae reveals novel species, host preference, and functional potential of this yet undescribed family. Microbiome. 2019;7:28. doi: 10.1186/s40168-019-0637-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40168-019-0637-2</ArticleId><ArticleId IdType="pmc">PMC6381624</ArticleId><ArticleId IdType="pubmed">30782206</ArticleId></ArticleIdList></Reference><Reference><Citation>Everard A., Belzer C., Geurts L., Ouwerkerk J.P., Druart C., Bindels L.B., Guiot Y., Derrien M., Muccioli G.G., Delzenne N.M., et al. Cross-talk between Akkermansia muciniphila and intestinal epithelium controls diet-induced obesity. Proc. Natl. Acad. Sci. USA. 2013;110:9066–9071. doi: 10.1073/pnas.1219451110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1219451110</ArticleId><ArticleId IdType="pmc">PMC3670398</ArticleId><ArticleId IdType="pubmed">23671105</ArticleId></ArticleIdList></Reference><Reference><Citation>Lozupone C.A., Stombaugh J.I., Gordon J.I., Jansson J.K., Knight R. Diversity, stability and resilience of the human gut microbiota. Nature. 2012;489:220–230. doi: 10.1038/nature11550.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature11550</ArticleId><ArticleId IdType="pmc">PMC3577372</ArticleId><ArticleId IdType="pubmed">22972295</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu B., Wang X., Li L. Human gut microbiome: The second genome of human body. Protein Cell. 2010;1:718–725. doi: 10.1007/s13238-010-0093-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s13238-010-0093-z</ArticleId><ArticleId IdType="pmc">PMC4875195</ArticleId><ArticleId IdType="pubmed">21203913</ArticleId></ArticleIdList></Reference><Reference><Citation>David L.A., Maurice C.F., Carmody R.N., Gootenberg D.B., Button J.E., Wolfe B.E., Ling A.V., Devlin A.S., Varma Y., Fischbach M.A., et al. Diet rapidly and reproducibly alters the human gut microbiome. Nature. 2014;505:559–563. doi: 10.1038/nature12820.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12820</ArticleId><ArticleId IdType="pmc">PMC3957428</ArticleId><ArticleId IdType="pubmed">24336217</ArticleId></ArticleIdList></Reference><Reference><Citation>Dethlefsen L., Huse S., Sogin M.L., Relman D.A. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol. 2008;6:e280. doi: 10.1371/journal.pbio.0060280.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.0060280</ArticleId><ArticleId IdType="pmc">PMC2586385</ArticleId><ArticleId IdType="pubmed">19018661</ArticleId></ArticleIdList></Reference><Reference><Citation>Mruk-Mazurkiewicz H., Kulaszyńska M., Czarnecka W., Podkówka A., Ekstedt N., Zawodny P., Wierzbicka-Woś A., Marlicz W., Skupin B., Stachowska E., et al. Insights into the Mechanisms of Action of Akkermansia muciniphila in the Treatment of Non-Communicable Diseases. Nutrients. 2024;16:1695. doi: 10.3390/nu16111695.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu16111695</ArticleId><ArticleId IdType="pmc">PMC11174979</ArticleId><ArticleId IdType="pubmed">38892628</ArticleId></ArticleIdList></Reference><Reference><Citation>Pellegrino A., Coppola G., Santopaolo F., Gasbarrini A., Ponziani F.R. Role of Akkermansia in Human Diseases: From Causation to Therapeutic Properties. Nutrients. 2023;15:1815. doi: 10.3390/nu15081815.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu15081815</ArticleId><ArticleId IdType="pmc">PMC10142179</ArticleId><ArticleId IdType="pubmed">37111034</ArticleId></ArticleIdList></Reference><Reference><Citation>Png C.W., Lindén S.K., Gilshenan K.S., Zoetendal E.G., McSweeney C.S., Sly L.I., McGuckin M.A., Florin T.H. Mucolytic bacteria with increased prevalence in IBD mucosa augment in vitro utilization of mucin by other bacteria. Am. J. Gastroenterol. 2010;105:2420–2428. doi: 10.1038/ajg.2010.281.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ajg.2010.281</ArticleId><ArticleId IdType="pubmed">20648002</ArticleId></ArticleIdList></Reference><Reference><Citation>Bäckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA. 2004;101:15718–15723. doi: 10.1073/pnas.0407076101.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0407076101</ArticleId><ArticleId IdType="pmc">PMC524219</ArticleId><ArticleId IdType="pubmed">15505215</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu S.C., Han F., Song M.R., Chen S., Li Q., Zhang Q., Zhu K., Shen J.Z. Natural flavones from Morus alba against methicillin-resistant Staphylococcus aureus via targeting the proton motive force and membrane permeability. J. Agric. Food Chem. 2019;67:10222–10234. doi: 10.1021/acs.jafc.9b01795.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.9b01795</ArticleId><ArticleId IdType="pubmed">31385700</ArticleId></ArticleIdList></Reference><Reference><Citation>Espinasse A., Goswami M., Yang J., Vorasin O., Ji Y., Carlson E.E. Targeting Multidrug Resistant Staphylococcus Infections with Bacterial Histidine Kinase Inhibitors. Chem. Sci. 2023;14:5028–5037. doi: 10.1039/D2SC05369A.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2SC05369A</ArticleId><ArticleId IdType="pmc">PMC10189854</ArticleId><ArticleId IdType="pubmed">37206395</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin M. Cutadapt removes adapter sequences from high-throughput sequencing reads. EMBnet. J. 2011;17:10–12. doi: 10.14806/ej.17.1.200.</Citation><ArticleIdList><ArticleId IdType="doi">10.14806/ej.17.1.200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramette A. Multivariate analyses in microbial ecology. FEMS Microbiol. Ecol. 2007;62:142–160. doi: 10.1111/j.1574-6941.2007.00375.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6941.2007.00375.x</ArticleId><ArticleId IdType="pmc">PMC2121141</ArticleId><ArticleId IdType="pubmed">17892477</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>